BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6193801)

  • 1. Problems of interpretation of serum concentrations of alpha-foetoprotein (AFP) in patients receiving cytotoxic chemotherapy for malignant germ cell tumours.
    Coppack S; Newlands ES; Dent J; Mitchell H; Goka G; Bagshawe KD
    Br J Cancer; 1983 Sep; 48(3):335-40. PubMed ID: 6193801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-1 antitrypsin (AAT) and alphafoetoprotein (AFP) in sera of patients with germ-cell neoplasms: value as tumour markers in patients with endodermal sinus tumour (yolk sac tumour).
    Talerman A; Haije WG; Baggerman L
    Int J Cancer; 1977 Jun; 19(6):741-6. PubMed ID: 68937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum alpha1-foetoprotein levels in 153 male patients with germ cell tumours.
    Grigor KM; Detre SI; Kohn J; Neville AM
    Br J Cancer; 1977 Jan; 35(1):52-8. PubMed ID: 64253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of the 'maturation' of metastases from germ cell tumours after intensive chemotherapy.
    McCartney AC; Paradinas FJ; Newlands ES
    Histopathology; 1984 May; 8(3):457-67. PubMed ID: 6203825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alphafetoprotein (AFP) in diagnosis and management of endodermal sinus (yolk sac) tumor and mixed germ cell tumor of the ovary.
    Talerman A; Haije WG; Baggerman L
    Cancer; 1978 Jan; 41(1):272-8. PubMed ID: 75054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum alpha-foetoprotein as a marker for endodermal sinus tumour (yolk sac tumour) or a vitelline component of "teratocarcinoma".
    Norgaard-Pedersen B; Albrechtsen R; Teilum G
    Acta Pathol Microbiol Scand A; 1975 Nov; 83(6):573-89. PubMed ID: 52995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-foetoprotein heterogeneity: what is its value in managing patients with germ cell tumours?
    de Takats PG; Jones SR; Penn R; Cullen MH
    Clin Oncol (R Coll Radiol); 1996; 8(5):323-6. PubMed ID: 8934053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
    Ballas M
    Ann Clin Lab Sci; 1974; 4(4):267-75. PubMed ID: 4142543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-foetoprotein and carcinoembryonic antigen in germ cell neoplasms.
    Talerman A; van der Pompe WB; Haije WG; Baggerman L; Boekestein-Tjahjadi HM
    Br J Cancer; 1977 Mar; 35(3):288-91. PubMed ID: 66925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
    Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Takahashi Y; Taguchi T
    J Pediatr Hematol Oncol; 2008 Jun; 30(6):447-50. PubMed ID: 18525461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum tumour marker regression rate following chemotherapy for malignant teratoma.
    Horwich A; Peckham MJ
    Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1463-70. PubMed ID: 6209145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
    Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
    Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
    Begent RH; Chester KA; Walker LC; Tucker DF
    Br J Cancer; 1982 Feb; 45(2):217-22. PubMed ID: 6174138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
    Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
    Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localisation of alpha-fetoprotein (AFP) in germ cell tumours: evidence for AFP production by tissues different from endodermal sinus tumour.
    Wagener C; Menzel B; Breuer H; Weissbach L; Tschubel K; Henkel K; Gedigk P
    Oncology; 1981; 38(4):236-9. PubMed ID: 6165946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunological monitoring of the treatment of malignant neoplasms in childhood].
    Ordyniec J; Woźniak W; Czerwiński W; Mańkowski T
    Probl Med Wieku Rozwoj; 1982; 11():223-30. PubMed ID: 6184714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor markers in germ cell tumors. Clinical use and research aspects].
    Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
    Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha-fetoprotein in the management of germ cell tumors of the ovary.
    Bonazzi C; Colombo N; Lissoni A; Pittelli MR; Bini S; Mangioni C
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):53-8. PubMed ID: 2480424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression pattern of alpha fetoprotein level changed after treatment of malignant germ cell tumor.
    Sanersak S; Prueksritanond N
    J Med Assoc Thai; 2008 Mar; 91(3):287-94. PubMed ID: 18575279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.